logo-large
  • Browse Categories

Publications by authors named "M Zenatri"

Claim this Profile
A
Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.
Morgan Zenatri, Michael Collins, Tifanie Alberto, Antonio Farina, Sophie Collardeau-Frachon

Cancer Immunol Immunother· January 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer.
A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, S Cheeseman, P M Kubelac, M Zenatri

ESMO Open· September 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study.
M Zenatri, T Perennec, C Michon, F Gernier, J-M Grellard

Gynecol Oncol· August 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between post-operative hPG (circulating progastrin) detectable level and worse prognosis in glioblastoma.
L Doucet, A Cailleteau, L Vaugier, C Gourmelon, M Bureau, M Zenatri

ESMO Open· October 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: